Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cetuximab as Salvage Therapy in Patients With Neo Wild-type RAS/RAF Metastatic Colorectal Cancer With Liver Metastases. A Proof-of-concept Study

NCT04189055 is registered in ClinicalTrials.gov with Hôpital Franco-Britannique-Fondation Cognacq-Jay as lead sponsor.

NCT NCT04189055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04189055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cetuximab as Salvage Therapy in Patients With Neo Wild-type RAS/RAF Metastatic Colorectal Cancer With Liver Metastases. A Proof-of-concept Study
Lead sponsor
Hôpital Franco-Britannique-Fondation Cognacq-Jay
Phase
Phase 2
Overall status
Unknown status
Start date
January 7, 2020
Completion date
July 31, 2024
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer colorectal